Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus.
Motolani E OgunsanyaS K ChoA HudsonBenjamin F ChongPublished in: The British journal of dermatology (2019)
The CLEQoL was found to be a valid and reliable PRO measure for assessing QoL in patients with CLE. Demonstrating that the CLEQoL has strong psychometric properties is an important step towards the development of a disease-specific PRO measure that future clinical trials can use.